December 9, 2014. We enthusiastically welcome further action from the FDA on all substances over which the Center for Food Safety and Applied Nutrition has authority. While the FDA has taken steps to address safety concerns regarding some substances, we strongly urge the agency to use its full authority to ensure the safety of all food-related and consumer products.
Read More »On Health Policy
NCHR Testimony at FDA Advisory Committee on Anti-Infective Drugs
December 4, 2014. Antibiotic resistance and the inability to treat common infections is an increasingly urgent public health crisis which affects everyone, especially some of the most vulnerable in our society. Finding treatment options for unmet populations is urgently important but ineffective antibiotics lead to an increase in antibiotic resistance.
Read More »NCHR Testimony at EPA Scientific Advisory Panel
December 3, 2014. Research has implicated endocrine-disrupting chemicals in cancer, infertility, and other health problems. We must be able to quickly identify such agents in order to prevent them from entering our food and environment, and from affecting our health for generations to come.
Read More »NCHR Testimony at FDA Risk Communication Advisory Committee on Fish Consumption
November 3, 2014. NCHR states that most consumers don’t want to have a long list of exactly what kind of fish to eat and what to avoid. If pregnant and breastfeeding women have avoided fish for themselves and for their young children, it’s because the messages they were getting were confusing. Come up with phrases that are easy to remember and and messages that are straightforward.
Read More »NCHR Comments on Social Media Platforms Presenting Risk and Benefit Information for Prescription Drugs and Medical Devices
October 29, 2014. NCHR states that patients and consumers increasingly rely on social media and the internet as sources of health and medical information that influence their decisions to seek medical care, and clarity is important.
Read More »